Company Overview of Ception Therapeutics, Inc.
Ception Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes new drugs. It offers Reslizumab for eosinophilic inflammatory conditions. The company also provides Anti-TNF, a class of small molecule anti-TNF receptor agents with the potential to be orally administered. Ception Therapeutics, Inc. was founded in 2004 and is based in Malvern, Pennsylvania. As of April 5, 2010, Ception Therapeutics, Inc. operates as a subsidiary of Cephalon, Inc.
101 Lindenwood Drive
Malvern, PA 19355
Founded in 2004
Key Executives for Ception Therapeutics, Inc.
Similar Private Companies By Industry
|Desert West Marketing Inc||United States|
|CerRx Inc.||United States|
|Bioplus Pharmaceuticals Inc.||United States|
|Carter-Wallace, Inc.||United States|
|Prevention Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- New York, NY | PwCPosted: Aug 20
- Chicago, IL | PwCPosted: Aug 20
- San Diego, CA | InventivPosted: Apr 17
Sponsored Financial Commentaries
To contact Ception Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.